Natco Pharma Half Yearly Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2023	Sep-2022	Mar-2022	Sep-2021	Mar-2021
Gross Sales	1390.40	1316.70	1157.30	787.50	686.50
Excise Duty	--	--	--	--	--
Net Sales	1390.40	1316.70	1157.30	787.50	686.50
Other Operating Income	--	--	--	--	--
Other Income	49.80	54.80	44	55	59.20
Total Income	1440.20	1371.50	1201.30	842.50	745.70
Total Expenditure	945.40	826.10	1074.10	607.20	527.80
PBIDT	494.80	545.40	127.20	235.30	217.90
Interest	6.50	8	11.70	6	6.90
PBDT	488.30	537.40	115.50	229.30	211
Depreciation	82.50	81.30	74.10	68.50	60.20
Minority Interest Before NP	--	--	--	--	--
Tax	76.50	86.20	16.10	31.70	33.50
Deferred Tax	(8.80)	(7.30)	(4.60)	(11)	0.90
Reported Profit After Tax	338.10	377.20	29.90	140.10	116.40
Minority Interest After NP	--	--	--	--	0.70
Net Profit after Minority Interest	338.10	377.20	29.90	140.10	115.70
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	338.10	377.20	29.90	140.10	115.70
EPS (Unit Curr.)	18.53	20.66	1.64	7.68	6.34
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	212.50	--	125	--
Equity	36.50	36.50	36.50	36.50	36.50
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	35.59	41.42	10.99	29.88	31.74
PBDTM(%)	--	--	--	--	--
PATM(%)	24.32	28.65	2.58	17.79	16.96

QuickLinks for Natco Pharma Ltd.